Shares in a2 tumble as company slashes forecast

Friday, 18 December 2020

A2 has slashed its forecast after losing Chinese resellers and other problems.

Shares in dairy company a2 have plunged more than 20 per cent on Friday as the company slashed its forecast to reflect a longer than expected recovery in its some of its selling channels.

The glamour stock’s share price fell more than 23 per cent to $10.78 in late afternoon trading, after a2 downgraded its revenue forecast for the first half to $670 million, and between $1.40 billion to $1.55b for the full year.

That was well down on 2020’s stellar full year revenue of $1.73b, and its September guidance of $1.8b to $1.9b, with $725m to $775m for the first half.

The numbers excluded any costs relating to its potential $270m acquisition of an interest in Mataura Valley Milk.

* A2 Milk benefits from Covid-19 'pantry stocking', posts record $386 million profit

A2 managing director Geoff Babidge. The company has hit turbulence over some of its selling channels to China.

Previously the company said it was expecting its margin on group earnings before interest, tax, depreciation and amortisation (ebitda) to be around 31 per cent; it now expects ebitda of between 26 and 29 per cent.

Issues first began to be appear in August when a2 stated it was having a number of issues in its infant nutrition business as a result of Covid-19.

They included a pause in demand after customers stocked up in its third quarter, and lower than anticipated sales to its retail ‘’daigous’’ or resellers in Australia, which rely on tourists and international students.

In September the company advised it had also seen a drop in orders from its corporate daigous, due to the prolonged lockdown in Victoria.

‘’At that time, we believed this to be a single channel logistics issue and were of the view that the impact to the daigou channel would prove to be temporary, assuming stabilisation of Covid-19 related issues in Australia,’’ the company said in a statement.

But by November, there was uncertainty about the company being able to maintain its guidance.

Now the daigou issue had now proved to be ‘’more significant and protracted than was previously anticipated,’’ and the company said although this had mainly affected its infant nutrition sales, its other nutritionals segment was also now affected.

A2 said it was confident about the underlying health of the business and noted its liquid milk businesses in Australia and the USA had posted strong first half growth compared to the previous year.